<p>The Basel biotech priced its Nasdaq IPO at $17.00 a share, and Sanofi is putting in $50 million on the side. Here’s the math on Windward Bio’s debut. The Swiss company priced its initial public offering (IPO) on 12 November at $17.00 a share for 10,294,117 shares, which comes to about $175 million. </p>